Travere Therapeutics, Inc. (TVTX)
42.90
+0.33
(+0.78%)
USD |
NASDAQ |
May 18, 15:58
Travere Therapeutics Total Assets (Quarterly) : 555.19M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| AbbVie, Inc. | 136.46B |
| Mirum Pharmaceuticals, Inc. | 890.92M |
| Anika Therapeutics, Inc. | 179.39M |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 456.46M |
| Shareholders Equity (Quarterly) | 98.73M |
| Debt to Equity Ratio | 3.319 |
| Current Ratio | 3.130 |
| Net Debt Paydown Yield | 0.54% |